CD4++ CD25++ regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model

Author： Shim Jua   Lee Eun-So   Park Sun   Bang Dongsik   Sohn Seonghyang  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.13, Iss.7, 2011-08, pp. : 835-847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD4+ CD25+ regulatory T cells approach the clinic

By Edinger M.  

Cytotherapy, Vol. 10, Iss. 7, 2008-01 ,pp. : 655-656

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Therapeutic potential of CD4 + CD25 + regulatory T cells in allogeneic transplantation

By Cohen JL   Salomon BL  

Cytotherapy, Vol. 7, Iss. 2, 2005-05 ,pp. : 166-170

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis

By Keever-Taylor Ca   Browning Mb   Johnson Bd   Truitt Rl   Bredeson Cn   Behn B.   Tsao A.  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 144-157

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy

By Sumida Y.   Nakamura K.   Kanayama K.   Akiho H.   Teshima T.   Takayanagi R.  

Cytotherapy, Vol. 10, Iss. 7, 2008-01 ,pp. : 698-710

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Selection of autologous CD4+ T-cells for adoptive T-cell substitution in patients with CD23+ B-cell CLL

By Dettke M   Berger R   Jurko S   Mitterbauer G   Schwarzmeier JD   Höcker P  

Cytotherapy, Vol. 4, Iss. 2, 2002-03 ,pp. : 119-125

Ashgate Publishing Ltd

Access to resources Recommend Favorite